Publicly traded Bruker BioSciences Corp., a Billerica, Mass.-based company specializing in radiology instruments and products, will pay $914 million to acquire companies within the privately held Bruker BioSpin Group, which is involved in magnetic-resonance research and life-sciences technology. Both outfits are owned by the parent company Bruker.
Terms of the deal call for Bruker BioScience to pay $388 million in cash along with 57.5 million shares of stock valued at $526 million to acquire Bruker BioSpin. The proposed merger has been approved by both companys boards, but must still be voted on by Bruker BioScience shareholders. It must also receive regulatory approval. Officials expect the deal to close in early 2008. -- by Shawn Rhea